According to Star Combo Pharma latest financial reports the total liabilities of S66 is $6.07M, an increase of 11.56% to 2022. At the end of 2022 company had $5.44M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Star Combo Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $6.07M | 11.56% |
2022 | $5.44M | 12.75% |
2021 | $4.82M | -30.22% |
2020 | $6.91M | 181.87% |
2019 | $2.45M | - |